Browse By Bacterial Diseases
This page shows data for Anthrax disease.
Total Entries Retrieved: 9
| ID | Name of the vaccine | Disease name | Name of bacteria | Type of vaccine | Name of the manufacturer | Clinical Phase status | Route of administration | PubMed identifier | Clinical trial number |
|---|---|---|---|---|---|---|---|---|---|
| 1138 | BIOTHRAX | Anthrax | Bacillus anthracis | Inactivated | Emergent BioDefense Operations | Approved | Intramuscular | NA | NA |
| 1364 | AV7909 | Anthrax | Bacillus anthracis | NA | Emergent BioSolutions | Clinical - Phase 3 | Intramuscular | 33199078 | NCT03877926 |
| 1365 | rPA vaccine | Anthrax | Bacillus anthracis | Recombinant | PharmAthene UK Limited | Clinical - Phase 2 | NA | NA | NCT00170469 |
| 1366 | rPA-102 | Anthrax | Bacillus anthracis | Recombinant | VaxGen | Clinical - Phase 2 | Intramuscular | NA | NCT00100724 |
| 1367 | BW-1010 | Anthrax | Bacillus anthracis | Recombinant | Blue Willow Biologics | Clinical - Phase 1 | Intranasal | NA | NCT04148118 |
| 1368 | PA83-FhCMB | Anthrax | Bacillus anthracis | Recombinant | Fraunhofer, Centre for Molecular Biotechnology | Clinical - Phase 1 | NA | NA | NCT02239172 |
| 1369 | Px563L | Anthrax | Bacillus anthracis | Recombinant | Pfenex, Inc | Clinical - Phase 1 | Intramuscular | 34544599 | NCT02655549 |
| 1370 | RPA563 | Anthrax | Bacillus anthracis | Recombinant | Pfenex, Inc | Clinical - Phase 1 | Intramuscular | NA | NCT02655549 |
| 1371 | NasoShield | Anthrax | Bacillus anthracis | Viral vector | Altimmune, Inc. | Clinical - Phase 1 | NA | NA | NCT04415749 |